Search

Your search keyword '"Sorarù, Gianni"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Sorarù, Gianni" Remove constraint Author: "Sorarù, Gianni" Database Academic Search Index Remove constraint Database: Academic Search Index
57 results on '"Sorarù, Gianni"'

Search Results

1. Theory of mind, empathy and neuropsychological functioning in X-linked Spinal and Bulbar Muscular Atrophy: a controlled study of 20 patients.

2. Specific numerical processing impairment in ALS patients.

3. Natural history of upper motor neuron-dominant ALS.

4. Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients.

5. Muscle histopathology in upper motor neuron-dominant amyotrophic lateral sclerosis.

6. Spinal and bulbar muscular atrophy: Skeletal muscle pathology in male patients and heterozygous females

7. Six‐minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen.

8. Financial and numerical abilities: patterns of dissociation in neurological and psychiatric diseases.

9. A pilot trial with clenbuterol in amyotrophic lateral sclerosis.

10. CSF-venous leak responsible for spontaneous intracranial hypotension treated by endovascular venous route: First cases in Italy.

11. The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA).

12. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

13. The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA).

14. Neurodegeneration in the retina of motoneuron diseases: a longitudinal study in amyotrophic lateral sclerosis and Kennedy's disease.

15. Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure.

16. Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance.

17. Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen.

18. The relevance of migraine in the clinical spectrum of mitochondrial disorders.

19. Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice.

20. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis.

21. Evaluation of peripherin in biofluids of patients with motor neuron diseases.

22. The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis.

23. Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers.

24. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1.

25. MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease.

26. The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1.

27. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

28. Troponin T in spinal and bulbar muscular atrophy (SBMA).

29. Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients.

30. Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy.

31. Preliminary design and validation of the "6-K-scale" for bulbar symptoms evaluation in SBMA.

32. Brain MRI shows white matter sparing in Kennedy's disease and slow‐progressing lower motor neuron disease.

33. Collagen XIX Alpha 1 Improves Prognosis in Amyotrophic Lateral Sclerosis.

34. Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.

35. Factors predicting survival in ALS: a multicenter Italian study.

39. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.

40. Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.

42. Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients.

43. Skeletal Muscle Satellite Cells in Amyotrophic Lateral Sclerosis.

44. Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy.

45. Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study.

46. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia.

47. Parkinson-like features in ALS with predominant upper motor neuron involvement.

48. 6MWT as measure of motor function and endurance in SMA type 3 patients treated with nusinersen.

49. TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations.

50. Enhanced Neural Empathic Responses in Patients with Spino-Bulbar Muscular Atrophy: An Electrophysiological Study.

Catalog

Books, media, physical & digital resources